Molecular Biometrics Lands $12M in Financing from Safeguard, Oxford Bioscience | GenomeWeb
NEW YORK (GenomeWeb news) – Molecular Biometrics has reeled in $12 million in Series A financing from Safeguard Scientifics and Oxford Bioscience Partners, Safeguard said today.
The metabolomics-based diagnostics company plans to use the funding for research and development for its ViaMetrics-E product, which is a test used to identify which embryos have the greatest reproductive potential for use in in vitro fertilization, and to launch the technology next year in Europe, Japan, and Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.